CHRS
Coherus Biosciences Inc. (CHRS)
NASDAQ · Healthcare
Coherus Biosciences Inc. annual/quarterly revenue history and growth rate from 2012 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Coherus Biosciences Inc. revenue for the quarter ending March 31, 2026 was 12.3 M, a 61.99% increase year-over-year.
- Coherus Biosciences Inc. revenue for the twelve months ending March 31, 2026 was 41.7 M, a 55.23% decrease year-over-year.
- Coherus Biosciences Inc. annual revenue for 2025 was 42.2 M, a 59.81% increase from 2024.
- Coherus Biosciences Inc. annual revenue for 2024 was 26.4 M, a 89.74% decrease from 2023.
- Coherus Biosciences Inc. annual revenue for 2023 was 257.2 M, a 21.89% increase from 2022.
- Coherus Biosciences Inc. annual revenue for 2022 was 211.0 M.
Revenue
TRAILING 12 MONTHS · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Coherus Biosciences Inc. Earnings — FAQ
Coherus Biosciences Inc. (CHRS) earnings over the last 14 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see CHRS's earnings history?
The chart and table above show Coherus Biosciences Inc.'s earnings by year and by quarter, including the growth rate.